AtriCure Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 AtriCure Inc 公司

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Inc简介



公司代码ATRC

公司名称AtriCure Inc

上市日期Aug 05, 2005

CEOCarrel (Michael H)

员工数量1300

证券类型Ordinary Share

年结日Aug 05

公司地址7555 Innovation Way

城市MASON

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编45040

电话15137554100

网址https://www.atricure.com

公司代码ATRC

上市日期Aug 05, 2005

CEOCarrel (Michael H)

AtriCure Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

698.94K

-4000.00%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+822.00%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+15401.00%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

78.80K

-5166.00%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

71.87K

-2500.00%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+822.00%

Mr. Sven A. Wehrwein, CPA

Independent Director

34.37K

--

Ms. Regina E. (Reggie) Groves

Independent Director

33.72K

-2452.00%

Ms. Deborah H. (Deb) Telman

Independent Director

22.18K

+5401.00%

Mr. Shlomo Nachman

Independent Director

18.51K

+5401.00%

名称

名称/职务

职务

持股

持股变动

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

698.94K

-4000.00%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+822.00%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+15401.00%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

78.80K

-5166.00%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

71.87K

-2500.00%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+822.00%

收入明细

单位: USD更新时间: 1月6日周二

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Appendage Management-United states

45.45M

33.85%

Open Ablation - United states

35.59M

26.51%

Pain management

20.84M

83.47%

Open ablation -International

10.85M

43.47%

Appendage management -International

10.17M

40.73%

其他

-97.94M

-128.04%

地区USD

名称

营收

占比

United States

109.31M

81.41%

Europe

15.17M

60.77%

Asia

8.08M

32.38%

Other international

1.71M

6.85%

业务

地区

业务USD

名称

营收

占比

Appendage Management-United states

45.45M

33.85%

Open Ablation - United states

35.59M

26.51%

Pain management

20.84M

83.47%

Open ablation -International

10.85M

43.47%

Appendage management -International

10.17M

40.73%

其他

-97.94M

-128.04%

股东统计

更新时间: 11月15日周六

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

9.84%

Wellington Management Company, LLP

8.63%

AllianceBernstein L.P.

7.16%

BlackRock Institutional Trust Company, N.A.

6.86%

Hood River Capital Management LLC

6.13%

其他

61.38%

持股股东

占比

The Vanguard Group, Inc.

9.84%

Wellington Management Company, LLP

8.63%

AllianceBernstein L.P.

7.16%

BlackRock Institutional Trust Company, N.A.

6.86%

Hood River Capital Management LLC

6.13%

其他

61.38%

股东类型

持股股东

占比

Investment Advisor

51.78%

Investment Advisor/Hedge Fund

39.96%

Hedge Fund

5.87%

Individual Investor

3.47%

Research Firm

1.65%

Pension Fund

0.75%

Bank and Trust

0.52%

Family Office

0.07%

Insurance Company

0.03%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

505

50.01M

100.59%

-8.38M

2025Q3

520

49.71M

119.25%

-705.98K

2025Q2

524

50.25M

121.23%

-1.55M

2025Q1

527

51.69M

113.33%

-4.41M

2024Q4

514

47.94M

122.38%

-3.05M

2024Q3

505

52.36M

125.18%

-207.95K

2024Q2

494

52.59M

116.92%

+1.07M

2024Q1

500

51.55M

109.93%

-1.63M

2023Q4

498

48.92M

106.78%

+1.54M

2023Q3

486

47.46M

108.31%

+99.25K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

4.83M

9.71%

-65.32K

-1.33%

Sep 30, 2025

Wellington Management Company, LLP

4.29M

8.63%

+322.82K

+8.13%

Sep 30, 2025

AllianceBernstein L.P.

3.56M

7.16%

-15.06K

-0.42%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

3.41M

6.86%

-34.35K

-1.00%

Sep 30, 2025

Hood River Capital Management LLC

3.05M

6.13%

-15.47K

-0.51%

Sep 30, 2025

Nomura Investment Management Business Trust

2.29M

4.6%

-213.84K

-8.54%

Sep 30, 2025

Champlain Investment Partners, LLC

1.98M

3.98%

-38.54K

-1.91%

Sep 30, 2025

State Street Investment Management (US)

1.26M

2.54%

-9.44K

-0.74%

Sep 30, 2025

Neuberger Berman, LLC

1.19M

2.4%

+1.37K

+0.12%

Sep 30, 2025

Geode Capital Management, L.L.C.

1.19M

2.4%

+9.32K

+0.79%

Sep 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

State Street SPDR S&P Health Care Equipment ETF

1.75%

Harbor Human Capital Factor US Small Cap ETF

0.7%

Invesco NASDAQ Future Gen 200 ETF

0.5%

First Trust Small Cap Growth AlphaDEX Fund

0.44%

Fidelity Enhanced Small Cap ETF

0.33%

Amplify Etho Climate Leadership U.S. ETF

0.3%

Franklin US Small Cap Multifactor Index ETF

0.25%

JPMorgan Fundamental Data Science Small Core ETF

0.24%

iShares U.S. Medical Devices ETF

0.2%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.17%

State Street SPDR S&P Health Care Equipment ETF

占比1.75%

Harbor Human Capital Factor US Small Cap ETF

占比0.7%

Invesco NASDAQ Future Gen 200 ETF

占比0.5%

First Trust Small Cap Growth AlphaDEX Fund

占比0.44%

Fidelity Enhanced Small Cap ETF

占比0.33%

Amplify Etho Climate Leadership U.S. ETF

占比0.3%

Franklin US Small Cap Multifactor Index ETF

占比0.25%

JPMorgan Fundamental Data Science Small Core ETF

占比0.24%

iShares U.S. Medical Devices ETF

占比0.2%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.17%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据